Form EFFECT Aprea Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 19, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aprea to present Phase 1 data on APR-1051 at EORTC-NCI-AACR symposium
- Best Crypto to Buy Under $1: Remittix Offers a Different Entry From XRP Ahead of November
- Shiba Inu Price Prediction: SHIB’s Recent 15% Weekly Rally Meets Remittix’s BINANCE500 Campaign
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
